Significant improvement in melanoma survival over the last decade A Hungarian nationwide study between 2011 and 2019 /
Recent real-world studies have reported significant improvements in the survival of malignant melanoma in the past few years, mainly as a result of modern therapies. However, long-term survival data from Central Eastern European countries such as Hungary are currently lacking.This nationwide, retros...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2023
|
| Sorozat: | JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
37 No. 5 |
| Tárgyszavak: | |
| doi: | 10.1111/jdv.18960 |
| mtmt: | 33647469 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/28532 |
| LEADER | 03148nab a2200421 i 4500 | ||
|---|---|---|---|
| 001 | publ28532 | ||
| 005 | 20231030110156.0 | ||
| 008 | 231030s2023 hu o 0|| Angol d | ||
| 022 | |a 0926-9959 | ||
| 024 | 7 | |a 10.1111/jdv.18960 |2 doi | |
| 024 | 7 | |a 33647469 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a Angol | ||
| 100 | 1 | |a Liszkay Gabriella | |
| 245 | 1 | 0 | |a Significant improvement in melanoma survival over the last decade |h [elektronikus dokumentum] : |b A Hungarian nationwide study between 2011 and 2019 / |c Liszkay Gabriella |
| 260 | |c 2023 | ||
| 300 | |a 932-940 | ||
| 490 | 0 | |a JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY |v 37 No. 5 | |
| 520 | 3 | |a Recent real-world studies have reported significant improvements in the survival of malignant melanoma in the past few years, mainly as a result of modern therapies. However, long-term survival data from Central Eastern European countries such as Hungary are currently lacking.This nationwide, retrospective study examined melanoma survival in Hungary between 2011-2019 using the databases of the National Health Insurance Fund (NHIF) and Central Statistical Office (CSO) of Hungary. Crude overall survival and age-standardized 5-year net survival as well as the association between age, sex, and survival were calculated.Between 2011 and 2019, 22,948 newly diagnosed malignant melanoma cases were recorded in the NHIF database (47.89% male, mean age: 60.75 years (SD: ±16.39)). 5-year overall survival was 75.40% (women: 80.78%; men: 69.52%). Patients diagnosed between 2017-2019 had a 20% lower risk of mortality compared to patients diagnosed between 2011-2012 (HR 0.80, 95% CI 0.73-0.89; p<0.0001). Age-standardized 5-year net survival rates in 2011-2014 and 2015-2019 were 90.6% and 95.8%, respectively (women: 93.1% and 98.4%, men: 87.8% and 92.7%, respectively). The highest age-standardized 5-year net survival rates were found in the 0-39 age cohort (94.6% in the 2015-2019 period).Hungary has similar melanoma survival rates to Western European countries. Based on net survival, the risk of dying of melanoma within 5 years was cut by more than half (55%) during the study period, which coincides with the successful implementation of awareness campaigns and the wide availability of modern therapies. | |
| 650 | 4 | |a Klinikai orvostan | |
| 700 | 0 | 1 | |a Benedek Angela |e aut |
| 700 | 0 | 1 | |a Polgár Csaba |e aut |
| 700 | 0 | 1 | |a Oláh Judit Magdolna |e aut |
| 700 | 0 | 1 | |a Holló Péter |e aut |
| 700 | 0 | 1 | |a Emri Gabriella |e aut |
| 700 | 0 | 1 | |a Csejtei András |e aut |
| 700 | 0 | 1 | |a Kenessey István |e aut |
| 700 | 0 | 1 | |a Polányi Zoltán |e aut |
| 700 | 0 | 1 | |a Knollmajer Kata |e aut |
| 700 | 0 | 1 | |a Várnai Máté |e aut |
| 700 | 0 | 1 | |a Vokó Zoltán |e aut |
| 700 | 0 | 1 | |a Nagy Balázs |e aut |
| 700 | 0 | 1 | |a Rokszin György Aurél |e aut |
| 700 | 0 | 2 | |a Bajcsayné Fábián Ibolya |e aut |
| 700 | 0 | 2 | |a Barcza Zsófia |e aut |
| 700 | 0 | 2 | |a Gyulai Rolland Péter |e aut |
| 700 | 0 | 2 | |a Kiss Zoltán |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/28532/1/AcadDermatolVenereol-2023-Liszkay-SignificantimprovementinmelanomasurvivaloverthelastdecadeAHungarian.pdf |z Dokumentum-elérés |